Healthcare provider profile · identity verified

Tara D Bournay, DO

Family Practice · TRAVERSE CITY, MI · NPI 1487090718

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	352	108
Lisinopril	Lisinopril	293	69
Omeprazole	Omeprazole	241	60
Levothyroxine Sodium	Levothyroxine Sodium	231	58
Metformin Hcl	Metformin Hcl	178	45
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	160	24
Amlodipine Besylate	Amlodipine Besylate	144	42
Hydrochlorothiazide	Hydrochlorothiazide	144	43
Alprazolam	Alprazolam	131	31
Rosuvastatin Calcium	Rosuvastatin Calcium	129	36
Trazodone Hcl	Trazodone Hcl	122	35
Metoprolol Succinate	Metoprolol Succinate	116	34
Eliquis	Apixaban	105	26
Gabapentin	Gabapentin	98	35
Tamsulosin Hcl	Tamsulosin Hcl	98	32
Albuterol Sulfate Hfa	Albuterol Sulfate	94	48
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	90	39
Tramadol Hcl	Tramadol Hcl	90	21
Losartan Potassium	Losartan Potassium	87	26
Prednisone	Prednisone	87	62
Sertraline Hcl	Sertraline Hcl	84	23
Simvastatin	Simvastatin	79	22
Escitalopram Oxalate	Escitalopram Oxalate	66	23
Pravastatin Sodium	Pravastatin Sodium	63	18
Meloxicam	Meloxicam	60	20
Fluoxetine Hcl	Fluoxetine Hcl	58	15
Doxycycline Hyclate	Doxycycline Hyclate	57	51
Duloxetine Hcl	Duloxetine Hcl	57	17
Furosemide	Furosemide	57	20
Alendronate Sodium	Alendronate Sodium	56	19
Metoprolol Tartrate	Metoprolol Tartrate	55	16
Montelukast Sodium	Montelukast Sodium	53	16
Citalopram Hbr	Citalopram Hydrobromide	52	14
Pantoprazole Sodium	Pantoprazole Sodium	51	19
Carvedilol	Carvedilol	47	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	45	45
Bupropion Hcl Sr	Bupropion Hcl	41	14
Cephalexin	Cephalexin	41	31
Lorazepam	Lorazepam	40	suppressed
Mounjaro	Tirzepatide	40	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	34
Levetiracetam	Levetiracetam	38	suppressed
Buspirone Hcl	Buspirone Hcl	37	11
Morphine Sulfate Er	Morphine Sulfate	37	suppressed
Risperidone	Risperidone	37	suppressed
Famotidine	Famotidine	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	26
Amitriptyline Hcl	Amitriptyline Hcl	34	11
Metformin Hcl Er	Metformin Hcl	34	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	34	13
Diazepam	Diazepam	32	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	32	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Atenolol	Atenolol	29	suppressed
Clobetasol Propionate	Clobetasol Propionate	29	20
Pregabalin	Pregabalin	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Allopurinol	Allopurinol	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Lovastatin	Lovastatin	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	24
Baclofen	Baclofen	25	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	25	suppressed
Glycopyrrolate	Glycopyrrolate	25	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Meclizine Hcl	Meclizine Hcl	23	12
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Azithromycin	Azithromycin	22	21
Methadone Hcl	Methadone Hcl	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Divalproex Sodium Er	Divalproex Sodium	21	suppressed
Estradiol	Estradiol	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Finasteride	Finasteride	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Ozempic	Semaglutide	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Naproxen	Naproxen	17	suppressed
Topiramate	Topiramate	17	suppressed
Glipizide	Glipizide	16	suppressed
Methylprednisolone	Methylprednisolone	16	13
Myrbetriq	Mirabegron	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Ondansetron Odt	Ondansetron	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	16	15
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Primidone	Primidone	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Norethindrone	Norethindrone	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Benzonatate	Benzonatate	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Nystatin	Nystatin	11	suppressed
Potassium Chloride	Potassium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error